Insider · CIK 0001706853

Malik Rajesh

Reports to the SEC for 2 companies · RESEARCH TRIANGLE PARK, NC

sec.gov

Transactions

Companies

Filings

CIK

0001706853

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-09-18	G1 Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+17.9K sh	—	—	177,212
2024-09-18	G1 Therapeutics, Inc.D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−89.8K sh	—	—	87,450
2024-09-18	G1 Therapeutics, Inc.U Disposition from Tender	Chief Medical Officer	UDisposition from Tender	−87.5K sh	—	—	0
2024-09-18	G1 Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−74.5K sh	—	—	0
2024-09-18	G1 Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−35.7K sh	—	—	0
2024-09-18	G1 Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−57.3K sh	—	—	0
2024-09-18	G1 Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−36.9K sh	—	—	0
2024-07-05	G1 Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−2,475 sh	$2.51	−$6,206.558	159,312
2024-05-13	G1 Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−8,151 sh	$4.79	−$39K	161,787
2024-02-12	G1 Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−28.6K sh	$4.62	−$132K	169,938
2024-02-12	G1 Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−28.6K sh	—	—	0
2024-02-12	G1 Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+28.6K sh	$0.30	+$8,580	198,538
2024-01-04	G1 Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−721 sh	$2.94	−$2,121.398	169,938
2024-01-03	G1 Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+37.3K sh	—	—	173,678
2024-01-03	G1 Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−758 sh	$3.12	−$2,364.126	172,920
2024-01-03	G1 Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−2,261 sh	$3.12	−$7,051.833	170,659
2024-01-03	G1 Therapeutics, Inc.Stock Options (Right to Buy)A Award	Chief Medical Officer	AAward	+74.5K sh	—	—	74,500
2023-12-27	POINT Biopharma Global Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2023-12-27	POINT Biopharma Global Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25.6K sh	—	—	0
2023-12-27	POINT Biopharma Global Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−44.7K sh	—	—	0
2023-12-26	POINT Biopharma Global Inc.U Disposition from Tender	Director	UDisposition from Tender	−3,700 sh	—	—	0
2023-12-11	G1 Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+21.4K sh	$0.39	+$8,361.21	157,817
2023-12-11	G1 Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−21.4K sh	$3.06	−$65.7K	136,378
2023-12-11	G1 Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+12.4K sh	$0.30	+$3,720	148,778
2023-12-11	G1 Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−12.4K sh	$4.02	−$49.9K	136,378
2023-12-11	G1 Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−12.4K sh	—	—	28,600
2023-12-11	G1 Therapeutics, Inc.Stock Options (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−21.4K sh	—	—	0
2023-07-05	G1 Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,361 sh	$2.45	−$3,339.486	136,378
2023-06-01	POINT Biopharma Global Inc.Stock Option (Right to Buy)A Award	Director	AAward	+44.7K sh	—	—	44,749
2023-05-10	G1 Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+35K sh	—	—	137,739
2023-01-05	G1 Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−729 sh	$5.41	−$3,942.067	102,739
2023-01-04	G1 Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,639 sh	$5.58	−$9,138.408	103,468
2023-01-03	G1 Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+17.9K sh	—	—	105,107
2023-01-03	G1 Therapeutics, Inc.Stock Options (Right to buy)A Award	Chief Medical Officer	AAward	+35.7K sh	—	—	35,700
2022-12-15	G1 Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+14K sh	$0.30	+$4,200	87,207
2022-12-15	G1 Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−14K sh	—	—	41,000
2022-11-28	POINT Biopharma Global Inc.P Purchase	Director	PPurchase	+3,700 sh	$6.66	+$24.6K	3,700
2022-09-13	G1 Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+18K sh	$0.39	+$7,020	91,207
2022-09-13	G1 Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−18K sh	$15.71	−$283K	73,207
2022-09-13	G1 Therapeutics, Inc.Stock Options (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−18K sh	—	—	21,439
2022-07-05	G1 Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−648 sh	$5.17	−$3,351.132	73,207
2022-06-02	POINT Biopharma Global Inc.Stock Option (Right to Buy)A Award	Director	AAward	+25.6K sh	—	—	25,614
2022-02-01	G1 Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+10K sh	$0.30	+$3,000	73,855
2022-02-01	G1 Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−10K sh	—	—	55,000
2022-01-05	G1 Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,445 sh	$10.61	−$15.3K	63,855
2022-01-03	G1 Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+12K sh	—	—	65,300
2022-01-03	G1 Therapeutics, Inc.Stock Options (Right to buy)A Award	Chief Medical Officer	AAward	+53K sh	—	—	53,000
2021-07-06	POINT Biopharma Global Inc.Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2021-05-10	G1 Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+10K sh	$0.30	+$3,000	53,300
2021-05-10	G1 Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−10K sh	—	—	65,000

Recent filings

Accepted (ET)
Sep 184
Malik Rajesh0000950170-24-107800
SEC(opens sec.gov)
Jul 84
Malik Rajesh0001562180-24-005658
SEC(opens sec.gov)
May 154
Malik Rajesh0001562180-24-004058
SEC(opens sec.gov)
Feb 134
Malik Rajesh0001562180-24-001296
SEC(opens sec.gov)
Jan 84
Malik Rajesh0001562180-24-000326
SEC(opens sec.gov)
Dec 274
Malik Rajesh0001104659-23-129770
SEC(opens sec.gov)

Companies

Address

C/O G1 THERAPEUTICS, INC. 79 T.W. ALEXANDER DRIVE

RESEARCH TRIANGLE PARK, NC, 27709